XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities    
Net Income (Loss) $ 2,849,000,000 $ 2,551,000,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation, depletion and amortization 2,746,000,000 2,211,000,000
Impairments 1,000,000 0
Dry hole costs and leasehold impairments 61,000,000 19,000,000
Accretion on discounted liabilities 94,000,000 80,000,000
Deferred taxes (71,000,000) 87,000,000
Distributions more (less) than income from equity affiliates (19,000,000) 308,000,000
(Gain) loss on dispositions (79,000,000) (93,000,000)
Other (115,000,000) (66,000,000)
Working capital adjustments    
Decrease (increase) in accounts and notes receivable 280,000,000 (76,000,000)
Decrease (increase) in inventories (26,000,000) (55,000,000)
Decrease (increase) in prepaid expenses and other current assets (134,000,000) 74,000,000
Increase (decrease) in accounts payable 518,000,000 (85,000,000)
Increase (decrease) in taxes and other accruals 10,000,000 30,000,000
Net Cash Provided by Operating Activities 6,115,000,000 4,985,000,000
Cash Flows From Investing Activities    
Capital expenditures and investments (3,378,000,000) (2,916,000,000)
Working capital changes associated with investing activities 827,000,000 169,000,000
Acquisition of businesses, net of cash acquired 0 49,000,000
Proceeds from asset dispositions 635,000,000 173,000,000
Net sales (purchases) of investments (400,000,000) 405,000,000
Other (30,000,000) (21,000,000)
Net Cash Used in Investing Activities (2,346,000,000) (2,141,000,000)
Cash Flows From Financing Activities    
Repayment of debt (547,000,000) (505,000,000)
Issuance of company common stock (52,000,000) (61,000,000)
Repurchase of company common stock (1,500,000,000) (1,325,000,000)
Dividends paid (998,000,000) (924,000,000)
Other (40,000,000) (10,000,000)
Net Cash Used in Financing Activities (3,137,000,000) (2,825,000,000)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 83,000,000 (73,000,000)
Net Change in Cash, Cash Equivalents and Restricted Cash 715,000,000 (54,000,000)
Cash, cash equivalents and restricted cash at beginning of period [1] 5,905,000,000 5,899,000,000
Cash, Cash Equivalents and Restricted Cash at End of Period [1] $ 6,620,000,000 $ 5,845,000,000
[1]
Restricted cash of $311 million and $298 million is included in the "Other assets" line of our Consolidated Balance Sheet as of March 31, 2025 and December 31, 2024, respectively.